Virus-like particles (VLPs) are virus-derived structures made up of one or more different
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …

Virus-like particles (VLPs) are self-assembled viral protein complexes that mimic the native
virus structure without being infectious. VLPs, similarly to wild type viruses, are able to …

Breast cancer (BC) is known to be a highly heterogeneous disease that is clinically
subdivided into four primary molecular subtypes, each having distinct morphology and …

Peptide vaccines have shown great potential in cancer immunotherapy by targeting tumor
antigens and activating the patient's immune system to mount a specific response against …

Toll-like receptor 2 (TLR2) expressed on myeloid cells mediates the recognition of harmful
molecules belonging to invading pathogens or host damaged tissues, leading to …

Because vaccine development is a difficult process, this study reviews aspects of phages as
vaccine delivery vehicles through a literature search. The results demonstrated that because …

Virus-like particles (VLPs) are empty, nanoscale structures morphologically resembling
viruses. Internal cavity, noninfectious, and particulate nature with a high density of repeating …

This review provides a comprehensive overview of the evolving landscape of cancer
vaccines, highlighting their potential to revolutionize tumor prevention. Building on the …

Breast cancer (BC) is one of the prevalent cancers among women. Generally, the treatment
of BC is mostly based on several prominent strategies, including chemotherapy, surgery …

Despite different strategies routinely applied for cancer therapy such as chemotherapy,
surgery, and radiotherapy or a combination of them, they are still beleaguered by poor long …